6 Papers
Esma Alp is an academic researcher from State University of New York System. The author has contributed to research in topics: Targeted drug delivery & DNA nanotechnology. The author has an hindex of 4, co-authored 4 publications. Previous affiliations of Esma Alp include Hacettepe University.
Chat about Author
Papers
Universal sensor array for highly selective system identification using two-dimensional nanoparticles
TL;DR: In this article, a highly selective universal sensor array using water-soluble two-dimensional nanoparticles (nGO, MoS2 and WS2) and fluorescent DNA molecules was used for the identification of three radically different systems; five proteins, three types of live breast cancer cells and a structure-switching event of a macromolecule.
Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment.
TL;DR: The findings suggest that encapsulation of CG-1521 into starch nanoparticles can improve drug delivery of histone deacetylase inhibitors for breast cancer therapy without interfering with the mechanism of action of the drug.
Molecular logic gate operations using one-dimensional DNA nanotechnology
TL;DR: Because of its outstanding signal amplification and programmability features, HCR-based 1D DNA nanotechnology is a promising building block for highly sensitive DNA-based bio-circuit assemblies.
24
Targeted delivery of etoposide to osteosarcoma cells using poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles
TL;DR: The results obtained in this study demonstrate that etoposide-loaded and FA-functionalized PHBV nanoparticles can be successfully used for targeted treatment of osteosarcoma.
The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility
TL;DR: In this paper , the authors investigated the mechanism by which MST1 regulates EPHA3 and revealed that the transcriptional regulators YAP1 and TEAD1 are crucial activators of EPHA-3 transcription.